CDO

(redirected from CTO)
Also found in: Dictionary, Thesaurus, Medical, Legal, Acronyms, Encyclopedia, Wikipedia.

CDO

Collateralized Debt Obligation

An asset-backed security backed by the receivables on loans, bonds, or other debt. Banks package and sell their receivables on debt to investors in order to reduce the risk of loss due to default. Returns on CDOs are paid in tranches; that is, the individual loans backing each CDO have different levels of risk, and investors are paid out according to the level of risk they have acquired. Banks offer higher interest rates to investors willing to buy CDOs backed by higher-risk loans. From a bank's perspective, in addition to reducing risk, CDOs also reduce their capital requirements because they can raise funds through the issue of CDOs. While, theoretically, CDOs can be backed by mortgages, one usually refers to these as collateralized mortgage obligations.

CDO

References in periodicals archive ?
For his part the CTO General Manager Mr Lawrence Thebe commended colleagues for the effort.
There is also need for future trials to compare the outcome of CTO PCI with CABG and medical therapy alone.
Abbreviations CTO: Chronic total occlusion LAD: Left anterior descending artery LCX: Left circumflex artery PCI: Percutaneous coronary artery RCA: Right coronary artery.
The letter, he said, was an attempt to refer them to earlier communications to parliament listing in detail the CTO's accomplishments in recent years.
He noted that the CTO could retain two thirds of the powers and responsibilities and give one third to the Deputy Ministry.
We invite you to contact our specialist Mental Health Team on 0191 246 8173, who will be happy to discuss any potential Hospital Managers Hearings or Tribunals and provide advice and guidance on the CTO.
Jive chairman and CEO Tony Zingale accepted the award at Morgan Stanley's 13th annual US CTO Summit held on June 5.
"The BridgePoint Medical CTO system is an addition to our suite of cardiology products," said Kevin Ballinger, president of the Interventional Cardiology Division at Boston Scientific.
As a result, the firm will gain a leading position in CTO technologies across the cardiovascular system, with its line-up also including the TruePath CTO Device and the investigational OffRoad CTO Device, Boston Scientific's CEO, Hank Kucheman, noted.Country: USASector: HealthcareTarget: BridgePoint Medical IncBuyer: Boston Scientific Corporation Type: Corporate acquisitionStatus: Agreed